[{"edinetCode":"E00962","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1905.0,"averageTemporaryStaff":183.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":19995000.0,"sharesOwendPercent":0.3682,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":3258.76,"equityRatio":0.843,"cashAndCashEquivalents":48098000000.0,"assets":186801000000.0,"currentAssets":97218000000.0,"fixedAsset":89582000000.0,"tangibleFixedAssets":26308000000.0,"intangibleFixedAssets":1845000000.0,"investmentAndOtherAssets":61428000000.0,"liabilities":29017000000.0,"currentLiabilities":15656000000.0,"shorTermDept":1800000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":13361000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1656000000.0,"netAsset":157783000000.0,"capitalStock":137499000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":101755000000.0,"treasuryStock":-12838000000.0,"valuationAndConversionAdjustments":19954000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":71706000000.0,"costOfSales":25076000000.0,"grossProfit":46630000000.0,"sgaExpenses":38140000000.0,"salaryAndBenefit":null,"depreciationAndSGA":695000000.0,"RDExpenses":13877000000.0,"operatingIncome":8491000000.0,"nonOperatingIncome":1271000000.0,"nonOperatingExpenses":124000000.0,"interestExpense":24000000.0,"ordinaryProfit":9638000000.0,"extraordinaryGain":670000000.0,"extraordinaryLoss":192000000.0,"incomeBeforeTax":10116000000.0,"incomeTaxes":2351000000.0,"netIncome":7765000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":7726000000.0,"comprehensiveIncome":3508000000.0,"eps":158.74,"dilutedEps":null,"dividendPerShare":null,"per":18.4,"roe":0.049,"cashFlowFromOperatingActivities":6441000000.0,"depreciationAndCashflowFromOperatingActivities":2370000000.0,"cashFlowFromInvestingActivities":-4671000000.0,"cashFlowFromFinancialActivities":-3766000000.0,"changesInCashAndCashEquivalents":-1996000000.0,"列1":"asr","submitDate":"2017\/6\/28","stockCode":4547,"accountingYear":"第72期（自? 平成28年４月１日? 至? 平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1903.0,"averageTemporaryStaff":177.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":18649000.0,"sharesOwendPercent":0.3992,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":3761.03,"equityRatio":0.825,"cashAndCashEquivalents":47360000000.0,"assets":213087000000.0,"currentAssets":100599000000.0,"fixedAsset":112487000000.0,"tangibleFixedAssets":26396000000.0,"intangibleFixedAssets":1716000000.0,"investmentAndOtherAssets":84374000000.0,"liabilities":36994000000.0,"currentLiabilities":17448000000.0,"shorTermDept":1757000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":19546000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1876000000.0,"netAsset":176092000000.0,"capitalStock":139809000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":102834000000.0,"treasuryStock":-11607000000.0,"valuationAndConversionAdjustments":35892000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":74009000000.0,"costOfSales":25878000000.0,"grossProfit":48131000000.0,"sgaExpenses":38232000000.0,"salaryAndBenefit":null,"depreciationAndSGA":784000000.0,"RDExpenses":14179000000.0,"operatingIncome":9887000000.0,"nonOperatingIncome":1558000000.0,"nonOperatingExpenses":32000000.0,"interestExpense":23000000.0,"ordinaryProfit":11414000000.0,"extraordinaryGain":320000000.0,"extraordinaryLoss":37000000.0,"incomeBeforeTax":11697000000.0,"incomeTaxes":2598000000.0,"netIncome":9098000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":9045000000.0,"comprehensiveIncome":25044000000.0,"eps":188.26,"dilutedEps":null,"dividendPerShare":null,"per":15.3,"roe":0.054,"cashFlowFromOperatingActivities":8845000000.0,"depreciationAndCashflowFromOperatingActivities":2492000000.0,"cashFlowFromInvestingActivities":-2959000000.0,"cashFlowFromFinancialActivities":-6621000000.0,"changesInCashAndCashEquivalents":-737000000.0,"列1":"asr","submitDate":"2018\/6\/27","stockCode":4547,"accountingYear":"第73期（自? 平成29年４月１日? 至? 平成30年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1907.0,"averageTemporaryStaff":169.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":18459000.0,"sharesOwendPercent":0.3951,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":3901.49,"equityRatio":0.854,"cashAndCashEquivalents":49315000000.0,"assets":213522000000.0,"currentAssets":95782000000.0,"fixedAsset":117739000000.0,"tangibleFixedAssets":25503000000.0,"intangibleFixedAssets":1519000000.0,"investmentAndOtherAssets":90716000000.0,"liabilities":30814000000.0,"currentLiabilities":13801000000.0,"shorTermDept":1764000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":17013000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1930000000.0,"netAsset":182707000000.0,"capitalStock":143001000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":106026000000.0,"treasuryStock":-11607000000.0,"valuationAndConversionAdjustments":39261000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":72297000000.0,"costOfSales":26735000000.0,"grossProfit":45562000000.0,"sgaExpenses":39363000000.0,"salaryAndBenefit":null,"depreciationAndSGA":909000000.0,"RDExpenses":15711000000.0,"operatingIncome":6202000000.0,"nonOperatingIncome":1224000000.0,"nonOperatingExpenses":257000000.0,"interestExpense":23000000.0,"ordinaryProfit":7169000000.0,"extraordinaryGain":4000000.0,"extraordinaryLoss":53000000.0,"incomeBeforeTax":7121000000.0,"incomeTaxes":1586000000.0,"netIncome":5535000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5481000000.0,"comprehensiveIncome":8903000000.0,"eps":117.33,"dilutedEps":null,"dividendPerShare":null,"per":24.7,"roe":0.031,"cashFlowFromOperatingActivities":6346000000.0,"depreciationAndCashflowFromOperatingActivities":2607000000.0,"cashFlowFromInvestingActivities":-2087000000.0,"cashFlowFromFinancialActivities":-2306000000.0,"changesInCashAndCashEquivalents":1954000000.0,"列1":"asr","submitDate":"2019\/6\/25","stockCode":4547,"accountingYear":"第74期（自? 2018年４月１日? 至? 2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.857,"cashAndCashEquivalents":null,"assets":210007000000.0,"currentAssets":97118000000.0,"fixedAsset":112889000000.0,"tangibleFixedAssets":25228000000.0,"intangibleFixedAssets":1452000000.0,"investmentAndOtherAssets":86208000000.0,"liabilities":29581000000.0,"currentLiabilities":14242000000.0,"shorTermDept":1759000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":15338000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1926000000.0,"netAsset":180426000000.0,"capitalStock":143846000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":106871000000.0,"treasuryStock":-11607000000.0,"valuationAndConversionAdjustments":36130000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":16099000000.0,"costOfSales":6065000000.0,"grossProfit":10034000000.0,"sgaExpenses":7984000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2061000000.0,"nonOperatingIncome":527000000.0,"nonOperatingExpenses":182000000.0,"interestExpense":5000000.0,"ordinaryProfit":2406000000.0,"extraordinaryGain":27000000.0,"extraordinaryLoss":2000000.0,"incomeBeforeTax":2431000000.0,"incomeTaxes":413000000.0,"netIncome":2018000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2012000000.0,"comprehensiveIncome":-1113000000.0,"eps":43.08,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":4547,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":18724000.0,"sharesOwendPercent":0.4008,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.846,"cashAndCashEquivalents":58859000000.0,"assets":220909000000.0,"currentAssets":98106000000.0,"fixedAsset":122803000000.0,"tangibleFixedAssets":25007000000.0,"intangibleFixedAssets":1475000000.0,"investmentAndOtherAssets":96319000000.0,"liabilities":33587000000.0,"currentLiabilities":14888000000.0,"shorTermDept":1754000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":18698000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1922000000.0,"netAsset":187322000000.0,"capitalStock":143984000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":107009000000.0,"treasuryStock":-11607000000.0,"valuationAndConversionAdjustments":42858000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":31548000000.0,"costOfSales":12862000000.0,"grossProfit":18686000000.0,"sgaExpenses":16364000000.0,"salaryAndBenefit":null,"depreciationAndSGA":471000000.0,"RDExpenses":5059000000.0,"operatingIncome":2334000000.0,"nonOperatingIncome":678000000.0,"nonOperatingExpenses":155000000.0,"interestExpense":11000000.0,"ordinaryProfit":2857000000.0,"extraordinaryGain":28000000.0,"extraordinaryLoss":16000000.0,"incomeBeforeTax":2870000000.0,"incomeTaxes":690000000.0,"netIncome":2179000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2150000000.0,"comprehensiveIncome":5782000000.0,"eps":46.04,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":11989000000.0,"depreciationAndCashflowFromOperatingActivities":1234000000.0,"cashFlowFromInvestingActivities":-1238000000.0,"cashFlowFromFinancialActivities":-1205000000.0,"changesInCashAndCashEquivalents":9544000000.0,"列1":"q2r","submitDate":"2019\/11\/13","stockCode":4547,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.846,"cashAndCashEquivalents":null,"assets":229299000000.0,"currentAssets":97532000000.0,"fixedAsset":131767000000.0,"tangibleFixedAssets":24705000000.0,"intangibleFixedAssets":1450000000.0,"investmentAndOtherAssets":105611000000.0,"liabilities":34881000000.0,"currentLiabilities":13166000000.0,"shorTermDept":1749000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":21714000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1918000000.0,"netAsset":194418000000.0,"capitalStock":144161000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":107186000000.0,"treasuryStock":-11607000000.0,"valuationAndConversionAdjustments":49753000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":48552000000.0,"costOfSales":20764000000.0,"grossProfit":27788000000.0,"sgaExpenses":25060000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2739000000.0,"nonOperatingIncome":1154000000.0,"nonOperatingExpenses":60000000.0,"interestExpense":17000000.0,"ordinaryProfit":3832000000.0,"extraordinaryGain":977000000.0,"extraordinaryLoss":17000000.0,"incomeBeforeTax":4793000000.0,"incomeTaxes":1199000000.0,"netIncome":3593000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3542000000.0,"comprehensiveIncome":14093000000.0,"eps":75.83,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/13","stockCode":4547,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1892.0,"averageTemporaryStaff":165.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":19408000.0,"sharesOwendPercent":0.4155,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":4119.89,"equityRatio":0.83,"cashAndCashEquivalents":59319000000.0,"assets":231794000000.0,"currentAssets":96677000000.0,"fixedAsset":135117000000.0,"tangibleFixedAssets":24605000000.0,"intangibleFixedAssets":1511000000.0,"investmentAndOtherAssets":108999000000.0,"liabilities":38824000000.0,"currentLiabilities":17024000000.0,"shorTermDept":1746000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":21800000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":13000000.0,"netAsset":192970000000.0,"capitalStock":143435000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":106461000000.0,"treasuryStock":-11608000000.0,"valuationAndConversionAdjustments":49029000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":63234000000.0,"costOfSales":28340000000.0,"grossProfit":34893000000.0,"sgaExpenses":33048000000.0,"salaryAndBenefit":null,"depreciationAndSGA":985000000.0,"RDExpenses":10767000000.0,"operatingIncome":1857000000.0,"nonOperatingIncome":1430000000.0,"nonOperatingExpenses":859000000.0,"interestExpense":23000000.0,"ordinaryProfit":2429000000.0,"extraordinaryGain":2264000000.0,"extraordinaryLoss":62000000.0,"incomeBeforeTax":4630000000.0,"incomeTaxes":1741000000.0,"netIncome":2888000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2817000000.0,"comprehensiveIncome":12646000000.0,"eps":60.31,"dilutedEps":null,"dividendPerShare":null,"per":46.1,"roe":0.015,"cashFlowFromOperatingActivities":13934000000.0,"depreciationAndCashflowFromOperatingActivities":2562000000.0,"cashFlowFromInvestingActivities":490000000.0,"cashFlowFromFinancialActivities":-4419000000.0,"changesInCashAndCashEquivalents":10004000000.0,"列1":"asr","submitDate":"2020\/6\/26","stockCode":4547,"accountingYear":"第75期（自? 2019年４月１日? 至? 2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.821,"cashAndCashEquivalents":null,"assets":260680000000.0,"currentAssets":87924000000.0,"fixedAsset":172755000000.0,"tangibleFixedAssets":24408000000.0,"intangibleFixedAssets":1513000000.0,"investmentAndOtherAssets":146833000000.0,"liabilities":46140000000.0,"currentLiabilities":15405000000.0,"shorTermDept":1746000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":30734000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":9000000.0,"netAsset":214539000000.0,"capitalStock":143947000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":106972000000.0,"treasuryStock":-11608000000.0,"valuationAndConversionAdjustments":70106000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":16061000000.0,"costOfSales":7803000000.0,"grossProfit":8258000000.0,"sgaExpenses":6625000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1633000000.0,"nonOperatingIncome":546000000.0,"nonOperatingExpenses":10000000.0,"interestExpense":5000000.0,"ordinaryProfit":2169000000.0,"extraordinaryGain":2000000.0,"extraordinaryLoss":0.0,"incomeBeforeTax":2171000000.0,"incomeTaxes":467000000.0,"netIncome":1703000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1725000000.0,"comprehensiveIncome":22783000000.0,"eps":36.94,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/11","stockCode":4547,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":19589000.0,"sharesOwendPercent":0.4193,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.82,"cashAndCashEquivalents":48098000000.0,"assets":266481000000.0,"currentAssets":91598000000.0,"fixedAsset":174883000000.0,"tangibleFixedAssets":24271000000.0,"intangibleFixedAssets":1514000000.0,"investmentAndOtherAssets":149097000000.0,"liabilities":47444000000.0,"currentLiabilities":15639000000.0,"shorTermDept":1746000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":31804000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5000000.0,"netAsset":219037000000.0,"capitalStock":146618000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":109643000000.0,"treasuryStock":-11608000000.0,"valuationAndConversionAdjustments":71898000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":32284000000.0,"costOfSales":16186000000.0,"grossProfit":16097000000.0,"sgaExpenses":14051000000.0,"salaryAndBenefit":null,"depreciationAndSGA":891000000.0,"RDExpenses":3548000000.0,"operatingIncome":2044000000.0,"nonOperatingIncome":758000000.0,"nonOperatingExpenses":22000000.0,"interestExpense":11000000.0,"ordinaryProfit":2780000000.0,"extraordinaryGain":2940000000.0,"extraordinaryLoss":9000000.0,"incomeBeforeTax":5711000000.0,"incomeTaxes":1310000000.0,"netIncome":4401000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4396000000.0,"comprehensiveIncome":27281000000.0,"eps":94.12,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1262000000.0,"depreciationAndCashflowFromOperatingActivities":1530000000.0,"cashFlowFromInvestingActivities":-8669000000.0,"cashFlowFromFinancialActivities":-1288000000.0,"changesInCashAndCashEquivalents":-11221000000.0,"列1":"q2r","submitDate":"2020\/11\/13","stockCode":4547,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.816,"cashAndCashEquivalents":null,"assets":262477000000.0,"currentAssets":94519000000.0,"fixedAsset":167957000000.0,"tangibleFixedAssets":24105000000.0,"intangibleFixedAssets":1639000000.0,"investmentAndOtherAssets":142212000000.0,"liabilities":47830000000.0,"currentLiabilities":18259000000.0,"shorTermDept":1746000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":29571000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1000000.0,"netAsset":214646000000.0,"capitalStock":147400000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":110425000000.0,"treasuryStock":-11608000000.0,"valuationAndConversionAdjustments":66682000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":52195000000.0,"costOfSales":26675000000.0,"grossProfit":25520000000.0,"sgaExpenses":22327000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":3190000000.0,"nonOperatingIncome":1436000000.0,"nonOperatingExpenses":55000000.0,"interestExpense":17000000.0,"ordinaryProfit":4570000000.0,"extraordinaryGain":4083000000.0,"extraordinaryLoss":83000000.0,"incomeBeforeTax":8570000000.0,"incomeTaxes":2080000000.0,"netIncome":6490000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":6440000000.0,"comprehensiveIncome":24152000000.0,"eps":137.86,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/12","stockCode":4547,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1863.0,"averageTemporaryStaff":166.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":19296000.0,"sharesOwendPercent":0.4184,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":4755.74,"equityRatio":0.816,"cashAndCashEquivalents":43447000000.0,"assets":268861000000.0,"currentAssets":92965000000.0,"fixedAsset":175895000000.0,"tangibleFixedAssets":24290000000.0,"intangibleFixedAssets":1640000000.0,"investmentAndOtherAssets":149964000000.0,"liabilities":48907000000.0,"currentLiabilities":18245000000.0,"shorTermDept":1743000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":30662000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":219953000000.0,"capitalStock":144941000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":109270000000.0,"treasuryStock":-12911000000.0,"valuationAndConversionAdjustments":74373000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":69044000000.0,"costOfSales":36321000000.0,"grossProfit":32723000000.0,"sgaExpenses":31217000000.0,"salaryAndBenefit":null,"depreciationAndSGA":1835000000.0,"RDExpenses":9626000000.0,"operatingIncome":1505000000.0,"nonOperatingIncome":2154000000.0,"nonOperatingExpenses":183000000.0,"interestExpense":23000000.0,"ordinaryProfit":3476000000.0,"extraordinaryGain":4087000000.0,"extraordinaryLoss":87000000.0,"incomeBeforeTax":7476000000.0,"incomeTaxes":2098000000.0,"netIncome":5378000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5285000000.0,"comprehensiveIncome":30762000000.0,"eps":113.25,"dilutedEps":null,"dividendPerShare":null,"per":21.6,"roe":0.026,"cashFlowFromOperatingActivities":-2542000000.0,"depreciationAndCashflowFromOperatingActivities":3148000000.0,"cashFlowFromInvestingActivities":-9329000000.0,"cashFlowFromFinancialActivities":-4000000000.0,"changesInCashAndCashEquivalents":-15872000000.0,"列1":"asr","submitDate":"2021\/6\/24","stockCode":4547,"accountingYear":"第76期（自? 2020年４月１日? 至? 2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.824,"cashAndCashEquivalents":null,"assets":261205000000.0,"currentAssets":91783000000.0,"fixedAsset":169422000000.0,"tangibleFixedAssets":24085000000.0,"intangibleFixedAssets":1612000000.0,"investmentAndOtherAssets":143723000000.0,"liabilities":45342000000.0,"currentLiabilities":17442000000.0,"shorTermDept":1739000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":27899000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":215862000000.0,"capitalStock":145868000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":110197000000.0,"treasuryStock":-12912000000.0,"valuationAndConversionAdjustments":69328000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":16635000000.0,"costOfSales":8769000000.0,"grossProfit":7866000000.0,"sgaExpenses":7573000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":293000000.0,"nonOperatingIncome":645000000.0,"nonOperatingExpenses":174000000.0,"interestExpense":5000000.0,"ordinaryProfit":764000000.0,"extraordinaryGain":3531000000.0,"extraordinaryLoss":22000000.0,"incomeBeforeTax":4273000000.0,"incomeTaxes":600000000.0,"netIncome":3672000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3644000000.0,"comprehensiveIncome":-1373000000.0,"eps":79.02,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/11","stockCode":4547,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":20941000.0,"sharesOwendPercent":0.4541,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.823,"cashAndCashEquivalents":48359000000.0,"assets":251056000000.0,"currentAssets":95595000000.0,"fixedAsset":155461000000.0,"tangibleFixedAssets":24328000000.0,"intangibleFixedAssets":1592000000.0,"investmentAndOtherAssets":129540000000.0,"liabilities":43857000000.0,"currentLiabilities":20565000000.0,"shorTermDept":1735000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":23292000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":207198000000.0,"capitalStock":147890000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":112219000000.0,"treasuryStock":-12911000000.0,"valuationAndConversionAdjustments":58620000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":32388000000.0,"costOfSales":16924000000.0,"grossProfit":15463000000.0,"sgaExpenses":15193000000.0,"salaryAndBenefit":null,"depreciationAndSGA":1034000000.0,"RDExpenses":4168000000.0,"operatingIncome":270000000.0,"nonOperatingIncome":1033000000.0,"nonOperatingExpenses":21000000.0,"interestExpense":11000000.0,"ordinaryProfit":1281000000.0,"extraordinaryGain":6634000000.0,"extraordinaryLoss":642000000.0,"incomeBeforeTax":7273000000.0,"incomeTaxes":1558000000.0,"netIncome":5715000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5666000000.0,"comprehensiveIncome":-10037000000.0,"eps":122.87,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":931000000.0,"depreciationAndCashflowFromOperatingActivities":1755000000.0,"cashFlowFromInvestingActivities":5280000000.0,"cashFlowFromFinancialActivities":-1300000000.0,"changesInCashAndCashEquivalents":4912000000.0,"列1":"q2r","submitDate":"2021\/11\/12","stockCode":4547,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0},{"edinetCode":"E00962","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.835,"cashAndCashEquivalents":null,"assets":239574000000.0,"currentAssets":93865000000.0,"fixedAsset":145708000000.0,"tangibleFixedAssets":24106000000.0,"intangibleFixedAssets":1609000000.0,"investmentAndOtherAssets":119991000000.0,"liabilities":38897000000.0,"currentLiabilities":18357000000.0,"shorTermDept":1731000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":20540000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":200676000000.0,"capitalStock":147751000000.0,"capital":24356000000.0,"capitalSurplus":24226000000.0,"accumulatedEarnings":112080000000.0,"treasuryStock":-12911000000.0,"valuationAndConversionAdjustments":52197000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":50085000000.0,"costOfSales":25976000000.0,"grossProfit":24108000000.0,"sgaExpenses":24402000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":-294000000.0,"nonOperatingIncome":1746000000.0,"nonOperatingExpenses":101000000.0,"interestExpense":17000000.0,"ordinaryProfit":1350000000.0,"extraordinaryGain":8005000000.0,"extraordinaryLoss":643000000.0,"incomeBeforeTax":8713000000.0,"incomeTaxes":1810000000.0,"netIncome":6903000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":6819000000.0,"comprehensiveIncome":-15268000000.0,"eps":147.87,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/10","stockCode":4547,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00962","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":24356,"settlementDate":"2022\/3\/31","submitterName":"キッセイ薬品工業株式会社","submitterNameEnglish":"KISSEI PHARMACEUTICAL CO.,LTD.","submitterNameKana":"キッセイヤクヒンコウギョウカブシキガイシャ","location":"松本市芳野１９番４８号","industory":"医薬品","corporateNumber":1100000000000.0}]